As your health and wellbeing are our priority, Dr Taylor and the CAPS Clinic team want to reassure our clients who may be concerned about their breast implants, and the possibility of developing BIA-ALCL (Breast Implant Associated ALCL).
Dr Taylor is a fully qualified, trained and experienced plastic surgeon who has successfully placed breast implants in thousands of patients.
Dr Taylor is recognised as one of the first surgeons to establish and practice the 14 Point Plan in his surgery, long before it was even recommended. The 14 Point Plan aims to minimise the number of bacteria that can contaminate breast implants at the time of surgery.
Learn more about the 14 Point Plan for Safer Breast Implants. You can also rest assured knowing that our private hospital where your surgery was performed is fully accredited, safe and sterile, and meets all the NSQHS standards.
Dr Taylor has used Allergan breast implants with a rough textured surface but the stringency of his surgery and the environment in which he operates minimises your risk of issues, no matter what implant you receive.
What is BIA-ALCL? It is a rare type of lymphoma (not breast cancer) that is associated with bacterial contamination on the implant. You can read more on the ASPS (Australian Society of Plastic Surgeons) website or download their factsheet here.
The factors behind BIA-ALCL developing for those who have had breast implants include:
Unfortunately, it is more common in breast reconstruction than in augmentation.
The main symptom of BIA-ALCL is a very swollen breast (double the size), almost happening overnight.
If this occurs, we expect our clients would call us so we can act quickly to address the concern, no matter the potential cause (this is also a symptom of a breast seroma, so we would be testing for both). Diagnosis involves ultrasound and taking a sample of the fluid.
Routine implant removal is not indicated for asymptomatic women with breast implants including textured implants.
The risk of BIA-ALCL with roughly textured implants is 1 in 2,800. To put this in perspective, all women have a lifetime risk of developing breast cancer of 1 in 8, whether or not they have breast implants. This risk of BIA-ALCL is greatly reduced if appropriate care is taken during the insertion operation.
Dr Taylor has been at the forefront of sterile implant insertion for many years and is confident for his patients, this is the case.
There have been concerns surrounding BIA-ALCL, which has led to roughly textured breast implants being withdrawn from sale in France, with the TGA in Australia currently discussing if there is sufficient evidence to warrant regulatory action.
If you are concerned or have further questions you can email firstname.lastname@example.org or call (02) 6282 1177 to speak to our Patient Services Team Monday to Friday 8am to 5pm